A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Melda Dolan
Jubilant DraxImage Inc., dba Jubilant Radiopharma
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford University
Palo Alto, California, United States
Robbie Majzner, MDNot, yet, recruiting - Ucsf Pediatric Hematology/oncology
San Francisco, California, United States
Kieuhoa Vo, MDRecruiting - Children'S Hospital Colorado
Aurora, Colorado, United States
Margaret Macy, MDRecruiting - Nemours Children'S Specialty Care
Jacksonville, Florida, United States
Manisha Bansal, MDRecruiting - University of Chicago Medical Center
Chicago, Illinois, United States
Ami V Desai, MDRecruiting - University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
David Dickens, MDRecruiting - Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Suzanne Shusterman, MDRecruiting - University of Minnesota
Minneapolis, Minnesota, United States
Emily Greengard, MDRecruiting - Washington University Medical Center in St. Louis
St Louis, Missouri, United States
Frederick Huang, MDRecruiting - Northwell Health /cohen Children'S Medical Center
New Hyde Park, New York, United States
Julie Krystal, MDRecruiting - Memorial Sloan Kettering Cancer Center
New York, New York, United States
Ellen Basu, MD, PhDRecruiting - Carolinas Medical Center/levine Children'S Hospital (atrium Health)
Charlotte, North Carolina, United States
Javier E Osterheld, MDRecruiting - Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
Brian Weiss, MDRecruiting - the Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Yael Mosse, MDRecruiting - Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Andrew Bukowinski, MDRecruiting - Upmc Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Andrew Bukowinski, MDRecruiting - University of Texas Southwestern Medical Center, Children'S Health
Dallas, Texas, United States
Tanya Watt, MDRecruiting - Cook Children'S Hematology/oncology Center
Fort Worth, Texas, United States
Meaghan Granger, MDRecruiting - Texas Children'S Hospital
Houston, Texas, United States
Jennifer Foster, MDRecruiting - Seattle Children'S Hospital
Seattle, Washington, United States
Navin R Pinto, MDRecruiting - University of Wisconsin, American Family Children'S Hospital and Clinical Science Center
Madison, Wisconsin, United States
Kenneth DeSantes, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Oct 2019
- Primary completion
- 1 Dec 2023
- Completion
- 30 Apr 2025
- Last update posted
- 16 Feb 2023
- Registered enrollment
- 60
- Registry id
- NCT03561259
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.